Low-dose naltrexone for post-COVID fatigue syndrome: a study protocol for a double-blind, randomised trial in British Columbia.
Naik H, Cooke E, Boulter T, Dyer R, Bone JN, Tsai M, Cristobal J, McKay RJ, Song X, Nacul L.
Naik H, et al.
BMJ Open. 2024 May 13;14(5):e085272. doi: 10.1136/bmjopen-2024-085272.
BMJ Open. 2024.
PMID: 38740499
Free PMC article.
INTRODUCTION: A significant proportion of individuals suffering from post COVID-19 condition (PCC, also known as long COVID) can present with persistent, disabling fatigue similar to myalgic encephalomyelitis/chronic fatigue syndrome (ME/ …
INTRODUCTION: A significant proportion of individuals suffering from post COVID-19 condition (PCC, also known as long …